Part D "Trial Size" Scripts Proposed, With Drug Tolerance And Waste In Mind
Executive Summary
A proposal to offer "trial size" prescriptions for Medicare Part D beneficiaries trying new medications to treat chronic conditions already has garnered some mixed reactions
You may also be interested in...
CMS Takes Second Shot At Mandating “Trial Size” Prescriptions For Part D; Estimates Savings At $2.5 Billion By 2018
CMS once again has proposed mandating that Medicare Part D prescription drug plan sponsors offer a “trial size” of first-fill prescriptions for medications treating chronic conditions and, in a step further than the previous effort, mandated that the cost-sharing be prorated based on the daily cost of the drug.
CMS Takes Second Shot At Mandating “Trial Size” Prescriptions For Part D; Estimates Savings At $2.5 Billion By 2018
CMS once again has proposed mandating that Medicare Part D prescription drug plan sponsors offer a “trial size” of first-fill prescriptions for medications treating chronic conditions and, in a step further than the previous effort, mandated that the cost-sharing be prorated based on the daily cost of the drug.
CMS Proposes "Trial Sizes" Of Prescriptions To Curb Waste Of Unused Drugs In Part D
Under a plan outlined in a draft Medicare Part D "call letter," patients receiving a new prescription for a drug previously unused by them would be able to receive an initial trial size supply of no more than seven to 14 days.